Related Articles
<em>In silico</em> and<em> in vitro</em> study of FLT3 inhibitors and their application in acute myeloid leukemia
CD155 and CD112 as possible therapeutic targets of <em>FLT3</em> inhibitors for acute myeloid leukemia
Synergistic effect of all‑trans retinoic acid in combination with protein kinase C 412 in FMS-like tyrosine kinase 3-mutated acute myeloid leukemia cells
Association of histologic subtypes with genetic alteration and PD‑L1 expression in pulmonary adenocarcinoma
Gene mutation profile and risk stratification in AML1‑ETO‑positive acute myeloid leukemia based on next‑generation sequencing